Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients. (LORIS)

Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study

MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.

However, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.

Study Overview

Detailed Description

Data from SONATA 2 CI recipients will be transferred to predefined fields in an electronic data capture system (CASTOR EDC) by the investigators. The data transfer starts after the approval of the Ethics Committees (EC). Data will be included for all subjects who meet the inclusion/exclusion criteria

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Madrid, Spain, 28046
      • Valencia, Spain, 46026
        • Hospital Universitario Y Politecnico La Fe
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

In this retrospective observational study, the inclusion and exclusion criteria encompass all individuals with a SONATA 2 cochlear implant at the study centers. By including all individuals with a SONATA 2 cochlear implant from the study centers, the investigation population is representative of the target population. The investigation population is representative of "real-world" users of SONATA 2 cochlear implant.

Description

Inclusion Criteria:

  • At least one MED-EL SONATA 2 cochlear implant with a compatible MED-EL audio processor

Exclusion Criteria:

  • Lack of compliance with any inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Bisyllables recognition score in quiet
Time Frame: pre-operative to 5 years post-operative
pre-operative to 5 years post-operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bisyllables recognition score in noise
Time Frame: pre-operative to 5 years post-operative
pre-operative to 5 years post-operative
Wearing time
Time Frame: up to 5 years post-operative
Wearing time in hours of audio processor used together with SONATA 2 cochlear implant
up to 5 years post-operative
Hardware and device parameters
Time Frame: up to 5 years post-operative
Descriptive summary of which electrode type and audio processor type was used together with a SONATA 2 cochlear implant
up to 5 years post-operative
Demographic information
Time Frame: pre-operative
descriptive summary of age at implantation, date of implantation, gender, type and duration of hearing loss, indications
pre-operative
Complications related to the device or procedure
Time Frame: up to 5 years post-operative
up to 5 years post-operative
Questionnaire scores
Time Frame: pre-operative to 5 years post-operative
Hearing Implant Sound Quality Index (HISQUI19)
pre-operative to 5 years post-operative
Questionnaire scores
Time Frame: pre-operative to 5 years post-operative
Speech, Spatial, and Qualities of Hearing Scale (SSQ)
pre-operative to 5 years post-operative
Questionnaire scores
Time Frame: pre-operative to 5 years post-operative
Nijmegen Cochlear Implant Questionnaire (NCIQ), LittlEars Auditory Questionnaire (LEAQ), Glasgow Benefit Inventory (GBI)
pre-operative to 5 years post-operative
Questionnaire scores
Time Frame: pre-operative to 5 years post-operative
LittlEars Auditory Questionnaire (LEAQ)
pre-operative to 5 years post-operative
Questionnaire scores
Time Frame: pre-operative to 5 years post-operative
Glasgow Benefit Inventory (GBI)
pre-operative to 5 years post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

June 24, 2026

First Submitted That Met QC Criteria

July 6, 2026

First Posted (Actual)

July 13, 2026

Study Record Updates

Last Update Posted (Actual)

July 13, 2026

Last Update Submitted That Met QC Criteria

July 6, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MED-EL_CRD_2025_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cochlear Implant

Clinical Trials on Transfer of data of SONATA 2 cochlear implant recipients

3
Subscribe